• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏临床症状的侵袭性生长激素瘤:神经外科治疗

Aggressive somatotrophinomas lacking clinical symptoms: neurosurgical management.

作者信息

Giordano Mario, Samii Amir, Fahlbusch Rudolf

机构信息

Department of Neurosurgery, International Neuroscience Institute-Hannover, Rudolf Pichlmayr Str. 4, 30625, Hannover, Germany.

Leibniz Institute for Neurobiology, Brenneckestrasse 6, 39118, Magdeburg, Germany.

出版信息

Neurosurg Rev. 2018 Oct;41(4):999-1005. doi: 10.1007/s10143-017-0940-y. Epub 2017 Dec 30.

DOI:10.1007/s10143-017-0940-y
PMID:29290044
Abstract

We report our experience about somatotrophinomas without clinical manifestation of acromegaly having radiological- and surgical-verified invasion of the cavernous sinus. We present the clinical, radiological and hormonal status of three patients affected by invasive GH-secreting pituitary adenomas without clinical signs and symptoms of acromegaly with elevation of serum IGF-1 from a series of 142 pituitary adenomas operated in our institute with the aid of intraoperative magnetic resonance imaging (MRI). Total tumor removal was possible in two of the three cases; the patients show normal hormonal status and no recurrence at long-term follow-up. In the third case, due to the different features of the tumor, complete resection was not possible and a multimodal treatment was performed that allowed regularization of the hormonal status and control of the residual tumor. GH-secreting adenomas without clinical manifestation of acromegaly are uncommon lesions. Total microsurgical excision can be curative. However, in case of partial removal, a tailored adjuvant treatment should be considered to preserve the quality of life of the patient and avoid regrowth of the lesion. In not resectable tumors, preoperative medical treatment with somatostatin analogues is always an option.

摘要

我们报告了关于无肢端肥大症临床表现但经影像学和手术证实侵犯海绵窦的生长激素瘤的经验。我们呈现了3例侵袭性生长激素分泌型垂体腺瘤患者的临床、影像学和激素状况,这些患者无肢端肥大症的临床体征和症状,血清胰岛素样生长因子-1(IGF-1)升高,来自于我们研究所借助术中磁共振成像(MRI)手术治疗的142例垂体腺瘤病例系列。3例中的2例实现了肿瘤全切;患者激素状况正常,长期随访无复发。在第3例中,由于肿瘤的不同特征,无法完全切除,因此进行了多模式治疗,使激素状况恢复正常并控制了残留肿瘤。无肢端肥大症临床表现的生长激素分泌型腺瘤是罕见病变。全显微手术切除可能治愈。然而,在部分切除的情况下,应考虑量身定制的辅助治疗,以维持患者生活质量并避免病变复发。对于不可切除的肿瘤,术前使用生长抑素类似物进行药物治疗始终是一种选择。

相似文献

1
Aggressive somatotrophinomas lacking clinical symptoms: neurosurgical management.缺乏临床症状的侵袭性生长激素瘤:神经外科治疗
Neurosurg Rev. 2018 Oct;41(4):999-1005. doi: 10.1007/s10143-017-0940-y. Epub 2017 Dec 30.
2
Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.肢端肥大症患者侵袭海绵窦肿瘤的积极经蝶窦切除术:预测因素、策略及结果
J Neurosurg. 2014 Sep;121(3):505-10. doi: 10.3171/2014.3.JNS132214. Epub 2014 Jul 11.
3
Endoscopic therapy and curative effect in pituitary adenoma patients complicated by acromegalic cardiomyopathy.垂体腺瘤合并肢端肥大症性心肌病患者的内镜治疗及疗效
Neurosurg Rev. 2018 Jul;41(3):869-875. doi: 10.1007/s10143-017-0936-7. Epub 2017 Dec 13.
4
Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly.术后 GH 和 IGF-1 降低程度可预测肢端肥大症术后激素缓解情况。
Front Endocrinol (Lausanne). 2021 Nov 18;12:743052. doi: 10.3389/fendo.2021.743052. eCollection 2021.
5
Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.经鼻内镜蝶窦入路垂体生长激素腺瘤切除术。
Neurosurg Focus. 2010 Oct;29(4):E6. doi: 10.3171/2010.7.FOCUS10173.
6
Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.生长激素型垂体腺瘤单纯经鼻蝶窦入路切除术的结果。
Neurosurg Focus. 2010 Oct;29(4):E5. doi: 10.3171/2010.7.FOCUS10153.
7
Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.基于影像学和激素结果比较经唇下显微手术入路(MSA)与鼻内镜下经鼻入路(EEA)治疗垂体腺瘤的疗效
Acta Neurochir Suppl. 2017;124:101-106. doi: 10.1007/978-3-319-39546-3_16.
8
Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria.经蝶窦入路治疗肢端肥大症:401例患者的缓解率及2010年共识标准
World Neurosurg. 2017 Dec;108:278-290. doi: 10.1016/j.wneu.2017.08.182. Epub 2017 Sep 5.
9
Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.单纯内镜经蝶窦手术治疗肢端肥大症:垂体中心治疗 67 例的结果。
Neurosurg Focus. 2010 Oct;29(4):E7. doi: 10.3171/2010.7.FOCUS10167.
10
Outcomes of Aggressive Surgical Resection in Growth Hormone-Secreting Pituitary Adenomas with Cavernous Sinus Invasion.侵袭海绵窦的生长激素分泌型垂体腺瘤积极手术切除的结果
World Neurosurg. 2018 Sep;117:e280-e289. doi: 10.1016/j.wneu.2018.06.012. Epub 2018 Jun 12.

引用本文的文献

1
Suspected silent pituitary somatotroph neuroendocrine tumor associated with acromegaly-like bone disorders: a case report.疑似与肢端肥大症样骨病相关的沉默性垂体生长激素细胞神经内分泌肿瘤:一例报告。
BMC Endocr Disord. 2024 Jul 23;24(1):121. doi: 10.1186/s12902-024-01657-7.

本文引用的文献

1
Silent somatotroph tumour revisited from a study of 80 patients with and without acromegaly and a review of the literature.重新探讨无肢端肥大症表现的生长激素腺瘤:来自 80 例伴或不伴肢端肥大症患者的研究及文献复习
Eur J Endocrinol. 2017 Feb;176(2):195-201. doi: 10.1530/EJE-16-0738. Epub 2016 Nov 15.
2
Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary.生长激素分泌型垂体腺瘤及垂体生长激素细胞增生的病理学
Pituitary. 2017 Feb;20(1):84-92. doi: 10.1007/s11102-016-0748-8.
3
Clinical Impact of the Current WHO Classification of Pituitary Adenomas.
世界卫生组织现行垂体腺瘤分类的临床影响
Endocr Pathol. 2016 Jun;27(2):104-14. doi: 10.1007/s12022-016-9418-7.
4
Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications.不典型垂体腺瘤的组织学标准——德国垂体腺瘤登记处的数据提示需要进行修正。
Acta Neuropathol Commun. 2015 Aug 19;3:50. doi: 10.1186/s40478-015-0229-8.
5
Silent pituitary adenomas.无功能性垂体腺瘤
Endocrinol Metab Clin North Am. 2015 Mar;44(1):79-87. doi: 10.1016/j.ecl.2014.11.001. Epub 2014 Nov 6.
6
Silent GH pituitary tumor: diagnostic and therapeutic challenges.生长激素腺瘤:诊断和治疗的挑战
Ann Endocrinol (Paris). 2013 Dec;74(5-6):491-5. doi: 10.1016/j.ando.2013.09.003. Epub 2013 Nov 19.
7
Aggressive silent GH pituitary tumor resistant to multiple treatments, including temozolomide.侵袭性无功能性垂体 GH 瘤,对包括替莫唑胺在内的多种治疗方法均耐药。
Cancer Invest. 2013 Mar;31(3):190-6. doi: 10.3109/07357907.2013.775293.
8
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up.一种新的垂体腺瘤预后临床病理分类:410 例患者 8 年术后随访的多中心病例对照研究。
Acta Neuropathol. 2013 Jul;126(1):123-35. doi: 10.1007/s00401-013-1084-y. Epub 2013 Feb 12.
9
Subclinical hyperfunctioning pituitary adenomas: the silent tumors.亚临床型功能性垂体腺瘤:沉默的肿瘤。
Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):447-60. doi: 10.1016/j.beem.2012.01.002. Epub 2012 May 22.
10
Clinically silent somatotroph adenomas are common.临床上无功能的生长激素腺瘤很常见。
Eur J Endocrinol. 2011 Jul;165(1):39-44. doi: 10.1530/EJE-11-0216. Epub 2011 Apr 14.